Altered Iron Metabolism and Ferroptosis in Polycystic Ovary Syndrome: Insights from a Meta-Analysis and Case-Control Study in Pregnant Women - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Altered Iron Metabolism and Ferroptosis in Polycystic Ovary Syndrome: Insights from a Meta-Analysis and Case-Control Study in Pregnant Women

  • By

  • Tianjing Wang

  • Weihuan Hu

  • Jue Zhou

  • Leyi Fu

  • Ningning Xie

  • Feng Yun

  • Jinlan Piao

  • Jing Lin

  • Danqing Chen

  • Fan Qu

  • Fangfang Wang

  • November 28, 2025

Share

Clinical Report: Altered Iron Metabolism and Ferroptosis in PCOS

Overview

This report investigates the relationship between ferroptosis-related iron metabolism and polycystic ovary syndrome (PCOS) in pregnant women. A meta-analysis and case-control study reveal elevated serum ferritin levels and reduced hepcidin levels in PCOS, suggesting a potential link to adverse pregnancy outcomes.

Background

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, with significant implications for fertility and pregnancy outcomes. Understanding the metabolic disturbances associated with PCOS, particularly regarding iron metabolism and ferroptosis, is crucial for improving management strategies. Recent findings indicate that dysregulated iron homeostasis may contribute to the pathophysiology of PCOS and its associated complications during pregnancy.

Data Highlights

No numerical data available in the provided source material.

Key Findings

  • Women with PCOS exhibit elevated serum ferritin levels and reduced serum hepcidin levels.
  • Ferroptosis may play a role in ovarian follicular atresia and could be a therapeutic target for managing ovulation in PCOS.
  • Iron overload in PCOS is linked to oxidative stress, which may contribute to adverse pregnancy outcomes.
  • Ferroptosis-related biomarkers warrant further investigation in the context of pregnancy complications associated with PCOS.
  • Meta-analyses indicate that PCOS is associated with higher risks of gestational diabetes and hypertensive disorders during pregnancy.

Clinical Implications

Healthcare providers should consider the implications of altered iron metabolism in women with PCOS, particularly during pregnancy. Monitoring serum ferritin and hepcidin levels may provide insights into the management of PCOS and its associated risks. Tailored interventions may be necessary to mitigate adverse pregnancy outcomes linked to ferroptosis.

Conclusion

The findings underscore the importance of understanding iron metabolism in PCOS and its potential impact on pregnancy. Further research is needed to clarify the mechanisms linking ferroptosis to adverse outcomes in this population.

Related Resources & Content

  1. Dysregulated iron metabolism related to ferroptosis in polycystic ovary syndrome: a meta-analysis and a case-control study in pregnant women, BMC Endocrine Disorders, 2025 -- Title
  2. Cytokine Profiling Across Diverse Populations Indicates Immune Dysregulation Rather Than Chronic Inflammation in Polycystic Ovary Syndrome, The Journal of Clinical Endocrinology & Metabolism, 2023 -- Title
  3. Metabolic Characteristics of Pregnancy in Women with Polycystic Ovary Syndrome: Understanding Maternal-Fetal Metabolic Interactions, The Journal of Clinical Endocrinology & Metabolism, 2023 -- Title
  4. Link Between Polycystic Ovary Syndrome and Pregnancy Outcomes in Gestational Diabetes Mellitus: Insights from a Secondary Analysis of the DiGest Study, The Journal of Clinical Endocrinology & Metabolism, 2023 -- Title
  5. International evidence-based recommendations for polycystic ovary syndrome in adolescents, BMC Medicine, 2025 -- Title
  6. Adverse pregnancy and perinatal outcomes in women with polycystic ovary syndrome undergoing assisted reproductive technology: a systematic review and meta-analysis, PMC, 2025 -- Title
  7. The Journal of Clinical Endocrinology & Metabolism — Exploring the Relationship Between Polycystic Ovary Syndrome, Metabolic Syndrome, and Inflammation in the Hispanic/Latino Health Study
  8. International evidence-based recommendations for polycystic ovary syndrome in adolescents | BMC Medicine | Full Text
  9. Adverse pregnancy and perinatal outcomes in women with polycystic ovary syndrome undergoing assisted reproductive technology: a systematic review and meta-analysis - PMC
  10. Dysregulated iron metabolism related to ferroptosis in polycystic ovary syndrome: a meta-analysis and a case-control study in pregnant women | BMC Endocrine Disorders | Springer Nature Link

Original Source(s)

Related Content